Beacons Of Hope: New Drugs That Can Cure Cancer, HPP & Cyctic Fibrosis

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.
ST. LOUIS, MO (KTVI) – These are the drugs covered in Tom Oneal’s special on FOX 2 News “Beacons Of Hope”.  They have been developed in the last few years to successfully treat and cure these devastating diseases.
Drugs Covered:
Interleukin-2 – This drug is used treat skin melanomas and kidney cancer. It is also being studied for use against some leukemias, lymphomas, and other cancers, as well as some other diseases.  More info
Kalydeco –  An oral medication to the treat cystic fibrosis.  It has been approved by the U.S. Food and Drug Administration.  It is the first drug available that targets a faulty gene and its protein product that is the cause of cystic fibrosis. More info
Asfotase Alfa  – This drug offers hope for rare, deadly disorder called HPP. It treats a rare genetic enzyme deficiency that causes bone softening and muscle weakness and can lead to severe lung problems and damage to other vital organs. It affects about 1 in 100,000 newborns worldwide.  About half of infants with a severe form of the disease do not survive beyond one year.  More info
Organizations Featured In This Report:
Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.